SAFETY OF LOW-DOSE PROLONGED INFUSION OF TISSUE PLASMINOGEN ACTIVATOR THERAPY IN PATIENTS WITH THROMBOEMBOLIC EVENTS IN THE INTENSIVE CARE UNIT

Kalkan M. E., Yildiz M., YILMAZ AK H., Agus H. Z., ÖZŞAHİN Y., AYKAN A. Ç., ...Daha Fazla

KARDIOLOGIYA, cilt.60, sa.7, ss.86-90, 2020 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 60 Sayı: 7
  • Basım Tarihi: 2020
  • Doi Numarası: 10.18087/cardio.2020.7.n1091
  • Dergi Adı: KARDIOLOGIYA
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE
  • Sayfa Sayıları: ss.86-90
  • İstanbul Üniversitesi Adresli: Evet

Özet

Objective Thromboembolic events such as acute coronary syndrome related prosthetic heart valve thrombosis, pulmonary artery embolism and renal artery embolism are a rare condition but a major cause of morbidity and mortality. In this study we discussed low-dose thrombolytic therapy, in patients with thromboembolic events in the intensive care unit.